Molecular diagnostics company Genetic Technologies (ASX:GTG) has announced the casual appointment of Eutillio Buccilli as its new executive director. [ + ]

Lonza has announced that it is holding a free webinar, titled 'Pluripotent Stem Cells - From Research to Therapy', on 17 June. The webinar is aimed at helping researchers streamline pluripotent stem cells (PSC) workflow through various stages of research and development. [ + ]

How can one protein's aggregates be the cause of several neurodegenerative disorders? Neurobiologists have discovered that the shape of these aggregates - 'cylinders' or 'ribbons' - determines whether a patient develops Parkinson's disease or multiple system atrophy, respectively. [ + ]

An international team of researchers, led by Harvard University Professor Charles Lieber, has developed a method for fabricating nanoscale electronic scaffolds that can be injected via syringe. [ + ]

The European Society of Clinical Microbiology and Infectious Diseases has announced University of Queensland Professor Jason Roberts as one of three winners of its 2015 Young Investigator Awards. [ + ]

The US FDA has reactivated the Investigational New Drug (IND) for the novel drug candidate PTX-100 (formerly known as GGTI-2418) in a phase Ib trial for the treatment of metastatic breast cancer. [ + ]

Phosphagenics (ASX:POH) has engaged the services of Dr Steve Meller to assist the company in partnering its TPM (Targeted Penetration Matrix) drug delivery technology with large companies selling into the mass market. [ + ]

Clinical Network Services (CNS), an integrated service group focused on clinical product development, has been announced as Australia's favourite CRO for 2015 by ARCS Australia. [ + ]

The Australian Government has begun the process to select Australia's next Chief Scientist, in preparation for the conclusion of Professor Ian Chubb's tenure at the end of the year. [ + ]

Members of the Combined Hunter Underwater Group (CHUG), Southern Cross University's (SCU) National Marine Science Centre and Underwater Volunteers NSW will this Saturday visit Nelson Bay, Port Stephens, to record and identify sea slug diversity. [ + ]

Women in Technology (WiT) is once again holding its annual awards program, with nominations open from now until 30 June. The technology industry association supports, develops, recognises and promotes the achievements of Queensland women in ICT and life sciences. [ + ]

Researchers from Sydney's Centenary Institute have discovered a pathway that may be vital for our understanding of allergic asthma - the prevalent form of childhood-onset asthma affecting 2 million Australians. [ + ]

Melbourne biotech Antisense Therapeutics (ASX:ANP) has announced an Early Access Program (EAP) for its multiple sclerosis (MS) therapy ATL1102 in the European Union, as well as a partnership with a US-based company to develop its growth disorder treatment ATL1103. [ + ]

Prana Biotechnology has announced that the European Commission has approved orphan designation for its lead drug candidate, PBT2, for the treatment of Huntington's disease. [ + ]

Researchers from Clemson University have developed a new urine testing method that is said to reduce costs, achieve faster results, lower the volume of fluid needed and remove the need for invasive blood tests. [ + ]